BayHelix members weigh in on Hong Kong exchange proposals

Results from a BayHelix Group survey show 85% of 117 respondents believe shares purchased by “cornerstone investors” should be included in the book-building process for biotechs looking to list on Hong Kong Exchanges and Clearing Ltd. (HKEX). The exchange has proposed excluding IPO shares bought by

Read the full 461 word article

User Sign In